The European Union medicines regulator recommended a conditional marketing authorization for U.S. drugmaker Pfizer’s therapy for a type of blood cancer that is difficult to treat.
Posts
Novavax Inc. announced today that the European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged 12 through 17.
